查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1764028

輸血設備市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、最終用途、地區和競爭細分，2020-2030 年）

Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球輸血設備市場規模為48億美元，預計2030年將達66.1億美元，複合年成長率為5.68%。輸血設備包括血袋、輸血過濾器、輸液幫浦和血液分離系統，對於確保血液成分的安全高效採集、處理和給藥至關重要。貧血、癌症、血友病和腎臟病等疾病的盛行率不斷上升，這些疾病通常需要反覆輸血，是推動市場成長的關鍵因素。

市場概覽
預測期 2026-2030
2024年市場規模 48億美元
2030年市場規模 66.1億美元
2025-2030 年複合年成長率 5.68%
成長最快的領域 血液分離系統
最大的市場 北美洲

此外，包括創傷和產科併發症在內的急診病例的增加，尤其是在醫療保健體係不斷擴展的發展中國家，持續推動需求成長。儘管資金和物流方面的挑戰依然存在，但由於技術進步、醫療支出增加以及對輸血實踐安全性和效率的日益重視，市場前景樂觀。隨著已開發市場和新興市場醫療基礎設施的不斷完善，先進輸血技術的整合必將加速。

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

高昂的資本和營運成本

主要市場趨勢

分散式採血模式的擴展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球輸血設備市場的影響

第5章：全球輸血設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（血液分離系統、輸液裝置、血液加溫器、靜脈通路裝置、過濾器等）
    • 依最終用途（醫院、門診手術中心、透析中心、血庫、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美輸血設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲輸血設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區輸血設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲輸血設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲輸血設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：全球輸血設備市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • Immucor Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Grifols SA
  • Kaneka Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Macopharma SA
  • Ecomed Solutions, LLC.

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 5061

The Global Blood Transfusion Devices Market was valued at USD 4.80 Billion in 2024 and is projected to reach USD 6.61 Billion by 2030, growing at a CAGR of 5.68%. Blood transfusion devices, which include blood bags, transfusion filters, infusion pumps, and apheresis systems, are vital for ensuring the safe and efficient collection, processing, and administration of blood components. The increasing prevalence of medical conditions such as anemia, cancer, hemophilia, and kidney disease-which often necessitate recurrent transfusions-is a key factor propelling market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.80 Billion
Market Size 2030USD 6.61 Billion
CAGR 2025-20305.68%
Fastest Growing SegmentApheresis Systems
Largest MarketNorth America

Additionally, the rise in emergency cases, including trauma and obstetric complications, particularly in developing nations with expanding healthcare systems, continues to drive demand. While financial and logistical challenges remain, the market outlook is positive due to technological advancements, increased healthcare spending, and heightened focus on safety and efficiency in transfusion practices. As both developed and emerging markets enhance their healthcare infrastructure, the integration of advanced transfusion technologies is set to accelerate.

Key Market Drivers

Growth in Healthcare Industry

The expanding global healthcare industry is a key driver supporting the growth of the blood transfusion devices market. Generating over USD 4 trillion annually, the healthcare sector includes pharmaceuticals, biotechnology, medical technology, and diagnostics-each playing a pivotal role in supporting transfusion needs.

Rising rates of surgical procedures, organ transplants, cancer treatments, and emergency interventions require reliable access to blood components like red cells, platelets, and plasma. However, disparities remain-only 6% of the 313 million global procedures occur in the poorest regions, despite these areas housing over a third of the global population. This imbalance results in higher fatality rates for treatable conditions. With more hospitals and clinics being established, especially in underserved regions, demand for transfusion equipment continues to rise, driven by both clinical need and improvements in infrastructure.

Key Market Challenges

High Capital and Operational Costs

The significant costs associated with blood transfusion equipment remain a major challenge for market expansion. Advanced technologies have improved the quality and safety of transfusion procedures but have also raised the financial barriers for adoption.

Establishing modern transfusion facilities requires substantial investment in equipment such as apheresis machines, automated processing systems, and temperature-controlled storage units. In low- and middle-income countries, these upfront and ongoing operational costs often hinder adoption, limiting the reach of quality transfusion care. Budget constraints among healthcare providers further exacerbate disparities in access, affecting both availability and patient outcomes.

Key Market Trends

Expansion of Decentralized Blood Collection Models

An important trend shaping the blood transfusion devices market is the transition toward decentralized collection models. To improve the resilience and reach of blood supply systems, healthcare systems are increasingly deploying mobile collection units, community-based sites, and rural health posts in addition to central facilities.

Innovations such as Touch Activated Phlebotomy (TAP) devices are enhancing the convenience and safety of decentralized blood collection by enabling painless, reliable, and self-administered capillary blood draws-without the need for trained phlebotomists. These models offer scalable, flexible solutions for broader population coverage, especially in hard-to-reach areas.

Key Market Players

  • Immucor Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Grifols SA
  • Kaneka Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Macopharma SA
  • Ecomed Solutions, LLC.

Report Scope

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Transfusion Devices Market, By Product:

  • Apheresis Systems
  • Infusion Devices
  • Blood Warmers
  • Venous Access Devices
  • Filters
  • Others

Blood Transfusion Devices Market, By End Use:

  • Hospital
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Blood Bank
  • Others

Blood Transfusion Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.

Available Customizations

Global Blood Transfusion Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood Transfusion Devices Market

5. Global Blood Transfusion Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
    • 5.2.2. By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Blood Transfusion Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Transfusion Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Blood Transfusion Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Blood Transfusion Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Blood Transfusion Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Blood Transfusion Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Blood Transfusion Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Blood Transfusion Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Blood Transfusion Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Blood Transfusion Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Blood Transfusion Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Transfusion Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Blood Transfusion Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Blood Transfusion Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Blood Transfusion Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Blood Transfusion Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. South America Blood Transfusion Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood Transfusion Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Blood Transfusion Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Blood Transfusion Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Blood Transfusion Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood Transfusion Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Blood Transfusion Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Blood Transfusion Devices Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Immucor Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Becton Dickinson and Company
  • 16.3. B. Braun Melsungen AG
  • 16.4. Terumo Corporation
  • 16.5. Grifols SA
  • 16.6. Kaneka Corporation
  • 16.7. Fresenius Kabi AG
  • 16.8. Haemonetics Corporation
  • 16.9. Macopharma SA
  • 16.10. Ecomed Solutions, LLC.

17. Strategic Recommendations

18. About Us & Disclaimer